Genmab A/S was incorporated on June 11, 1998. The Company is an international biotechnology company with a portfolio of novel antibody-based products and product candidates designed to meet the medical needs of patients with cancer and other serious diseases and improve their treatment outcomes. The company's goal in establishing its product line is to bring drugs to market in geographic areas where they believe they can maximize their value and have a meaningful impact on the therapeutic field. 

GMAB

GMAB Profile